(Q30249025)

13 June 2017

1 reference

title

Virus like particle-based vaccines against emerging infectious disease viruses (English)

1 reference

27405928

emerging communicable disease

13 June 2017

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Jinliang Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Shiyu Dai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Manli Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hualin Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Fei Deng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

11 July 2016

1 reference

13 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

279-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

Hantavirus Gn and Gc glycoproteins self-assemble into virus-like particles

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Norovirus vaccine against experimental human Norwalk Virus illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Emergence of Zaire Ebola Virus Disease in Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Developments in virus-like particle-based vaccines for infectious diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Determinants of autoantibody induction by conjugated papillomavirus virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Novel vaccine strategies against emerging viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Paramyxovirus assembly and budding: building particles that transmit infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Norwalk virus-like particles as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Influenza vaccines based on virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Effective chikungunya virus-like particle vaccine produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Human Norovirus as a Foodborne Pathogen: Challenges and Developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Characterization of chikungunya virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Generation and analysis of infectious virus-like particles of uukuniemi virus (bunyaviridae): a useful system for studying bunyaviral packaging and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Noroviruses: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Epidemiology of human noroviruses and updates on vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Virus-like particles in vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Virus-like particles produced in plants as potential vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Chikungunya fever: an epidemiological review of a re-emerging infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Vaccine potential of Nipah virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Advances in virus-like particle vaccines for filoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Ebola virus-like particles protect from lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Efficient production of Japanese encephalitis virus-like particles by recombinant lepidopteran insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Construction and characterization of virus-like particles: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Virus-like particle-based human vaccines: quality assessment based on structural and functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Production of CCHF virus-like particle by a baculovirus-insect cell expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-016-3756-Y

Recombinant Norwalk virus-like particles as an oral vaccine.

21 January 2018

1 reference

12 December 2020

Taxonomic status of the Tyulek virus (TLKV) (Orthomyxoviridae, Quaranjavirus, Quaranfil group) isolated from the ticks Argas vulgaris Filippova, 1961 (Argasidae) from the birds burrow nest biotopes in the Kyrgyzstan

1 reference

12 December 2020

Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice

1 reference

12 December 2020

Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.

1 reference

12 December 2020

Highly pathogenic avian influenza.

1 reference

12 December 2020

Arenaviruses. I. The epidemiology molecular and cell biology of arenaviruses. Introduction.

1 reference

12 December 2020

Retracted: Ebola virus: an introduction and its pathology

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/RMV.1863

Identifiers

DOI

10.1007/S12250-016-3756-Y

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405928%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

27405928

1 reference